AKT1 and lobular neoplasia: The integrated analysis using network pharmacology, transcriptomics, and metabolomics has revealed significant enrichment in pathways such as primary bile acid biosynthesis, the FOXO signaling pathway, and the PI3K-AKT signaling pathway in the treatment of LN with LCW.